PURA Launches EVERx CBD Sports Water Marketing Campaign In Europe Next Week
September 11 2019 - 9:00AM
InvestorsHub NewsWire
PURA Launches EVERx CBD Sports
Water Marketing Campaign In Europe Next Week
DALLAS, TX -- September 11, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (PURA)
today announced the launch of its EVERx CBD Sports Water marketing
campaign in Europe. The campaign will kick off at Arnold
Schwarzenegger’s Arnold Sports Festival Europe in Barcelona
September 20-22, 2019. EVERx CBD Sports Water is available
already in Europe through select distributors. With the EVERx
CBD Sports Water campaign starting next week, PURA plans to expand
its European sales. Look for more news from the event next
week, and in the weeks to follow, look for more news as the EVERx
CBD Sports Water marketing campaign in Europe continues to
grow.
EVERx was officially launched for the
first time ever at the Arnold Classic in Columbus, Ohio in
2017. EVERx now participates at the Arnold Sports
Festival events worldwide. EVERx today is the leading
CBD infused sports nutrition beverage with over $1 million in sales
in 2018 and over $1 million in sales in the first six months of
2019 and targeting $4 million in
sales by 2019 year end. EVERx is now an official sponsor
of Jan Tana’s
Body Painting Revolution featured globally at Arnold
Sports Festival venues worldwide.
EVERx CBD Sports Water is available for
purchase on line at www.USMJ.com hosted by PURA’s partner North American
Cannabis Holdings, Inc. (USOTC:
USMJ).
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024